TY - JOUR
T1 - Biomimetic Glucan Particles with Aggregation-Induced Emission Characteristics for Noninvasive Monitoring of Transplant Immune Response
AU - Gao, Tang
AU - Wu, Ya
AU - Wang, Wenyuan
AU - Deng, Cheng
AU - Chen, Yihan
AU - Yi, Luyang
AU - Song, Yishu
AU - Li, Wenqu
AU - Xu, Lingling
AU - Xie, Yuji
AU - Fang, Lingyun
AU - Jin, Qiaofeng
AU - Zhang, Li
AU - Tang, Ben Zhong
AU - Xie, Mingxing
N1 - Publisher Copyright:
© 2021 American Chemical Society.
PY - 2021/7/27
Y1 - 2021/7/27
N2 - Real-time monitoring of post-transplant immune response is critical to prolong the survival of grafts. The current gold standard for assessing the immune response to graft is biopsy. However, such a method is invasive and prone to false negative results due to limited tissue size available and the heterogeneity of the rejection site. Herein, we report biomimetic glucan particles with aggregation-induced emission (AIE) characteristics (HBTTPEP/GPs) for real-time noninvasive monitoring of post-transplant immune response. We have found that the positively charged near-infrared AIEgens can effectively aggregate in the confined space of glucan particles (GPs), thereby turning on the fluorescence emission. HBTTPEP/GPs can track macrophages for 7 days without hampering the bioactivity. Oral administration of HBTTPEP/GPs can specially target macrophages by mimicking yeast, which then migrate to the transplant rejection site. The fluorescence emitted from HBTTPEP/GPs correlated well with the infiltration of macrophages and the degree of allograft rejection. Furthermore, a single oral HBTTPEP/GPs dose can dynamically evaluate the therapeutic response to immunosuppressive therapy. Consequently, the biomimetic AIE-active glucan particles can be developed as a promising probe for immune-monitoring in solid organ transplantation.
AB - Real-time monitoring of post-transplant immune response is critical to prolong the survival of grafts. The current gold standard for assessing the immune response to graft is biopsy. However, such a method is invasive and prone to false negative results due to limited tissue size available and the heterogeneity of the rejection site. Herein, we report biomimetic glucan particles with aggregation-induced emission (AIE) characteristics (HBTTPEP/GPs) for real-time noninvasive monitoring of post-transplant immune response. We have found that the positively charged near-infrared AIEgens can effectively aggregate in the confined space of glucan particles (GPs), thereby turning on the fluorescence emission. HBTTPEP/GPs can track macrophages for 7 days without hampering the bioactivity. Oral administration of HBTTPEP/GPs can specially target macrophages by mimicking yeast, which then migrate to the transplant rejection site. The fluorescence emitted from HBTTPEP/GPs correlated well with the infiltration of macrophages and the degree of allograft rejection. Furthermore, a single oral HBTTPEP/GPs dose can dynamically evaluate the therapeutic response to immunosuppressive therapy. Consequently, the biomimetic AIE-active glucan particles can be developed as a promising probe for immune-monitoring in solid organ transplantation.
KW - aggregation-induced emission
KW - biomimicking
KW - glucan particles
KW - macrophages
KW - skin transplantation
KW - transplant immune monitoring
UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000679406500083
UR - https://openalex.org/W3182888913
UR - https://www.scopus.com/pages/publications/85111504404
U2 - 10.1021/acsnano.1c03029
DO - 10.1021/acsnano.1c03029
M3 - Journal Article
C2 - 34264052
SN - 1936-0851
VL - 15
SP - 11908
EP - 11928
JO - ACS Nano
JF - ACS Nano
IS - 7
ER -